Last reviewed · How we verify
NCT05569785
Bariatric Surgery and Exercise Interventions: Effects on Muscle
NA trial testing Resistance Exercise Therapy in Bariatric Surgery Candidate in 12 participants. Currently enrolling.
30 June 2024
Quick facts
| Lead sponsor | University of Nottingham |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 12 |
| Start date | 1 March 2023 |
| Primary completion | 30 June 2024 |
| Estimated completion | 1 December 2024 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Resistance Exercise Therapy
Conditions studied
- Bariatric Surgery Candidate — all drugs for Bariatric Surgery Candidate →
- Obesity — all drugs for Obesity →
Sponsor
University of Nottingham
Who can join
Adults 18 to 70, any sex, with Bariatric Surgery Candidate or Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this project is to assess the effects of bariatric surgery on muscle structure and function as well as investigating the feasibility of undertaking an exercise intervention post-surgery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05569785
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Bariatric Surgery Candidate
Currently open trials in the same condition.
- NCT07525232 — Stepwise PEEP vs Sustained Inflation in Bariatric Surgery Patients · NA · recruiting
- NCT06511310 — Exercise, Brain Activity, and Weight Maintenance · NA · recruiting
- NCT05966727 — Exploratory Evaluation of the Effect of Cholestyramine on Serum Levels of POPs in Obese Female Patients · NA · recruiting
- NCT06915558 — Modulation of the Inflammatory Response in Bariatric Surgery · recruiting
- NCT06689241 — Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Bariatric Surgery · NA · recruiting
Other University of Nottingham trials
Trials by the same sponsor.
- NCT07518381 — Medication Understanding in MS · not yet recruiting
- NCT07355556 — Technology Supported Improvement, Management and Prevention of Accidental Falls in Hospitals · not yet recruiting
- NCT07506408 — Randomised Study of Web-Based Auditory Training With Varying Perceptual and Cognitive Demands on Training Gains and Gene · NA · recruiting
- NCT07237529 — What is the Feasibility of Narrative Exposure Therapy (NET) for People Experiencing Psychosis? · NA · not yet recruiting
- NCT07237997 — Protein Supplementation During Dialysis (PROSED) · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05569785 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Nottingham
- Last refreshed: 20 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05569785.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing